Ectosomes obtained from patients with malignant breast cancer exhibited elevated expression of several surface antigens (CD66; human epidermal growth factor receptor 2, Her2/neu; breast cancer resistance protein, BRCP; Hsp27) as compared with benign tumors, suggesting their potential use as relevant diagnostic markers for malignancy [87]. The gene discussed is ERBB2; the disease is benign neoplasm.